Enhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent process.
about
Enhanced bioavailability of apigenin via preparation of a carbon nanopowder solid dispersion.Fabrication and evaluation of valsartan-polymer- surfactant composite nanoparticles by using the supercritical antisolvent processSurface engineering of porous silicon microparticles for intravitreal sustained delivery of rapamycin.Enhanced oral bioavailability of fenofibrate using polymeric nanoparticulated systems: physicochemical characterization and in vivo investigation.Preparation and in vivo evaluation of a dutasteride-loaded solid-supersaturatable self-microemulsifying drug delivery system.Development of megestrol acetate solid dispersion nanoparticles for enhanced oral delivery by using a supercritical antisolvent processFormation of methotrexate-PLLA-PEG-PLLA composite microspheres by microencapsulation through a process of suspension-enhanced dispersion by supercritical CO2.In Vitro and In Vivo Sustained Zero-Order Delivery of Rapamycin (Sirolimus) From a Biodegradable Intraocular Device.Increasing the oral bioavailability of poorly water-soluble carbamazepine using immediate-release pellets supported on SBA-15 mesoporous silicaNew nanoformulation of rapamycin Rapatar extends lifespan in homozygous p53-/- mice by delaying carcinogenesisCharacterization and stability studies of a novel liposomal cyclosporin A prepared using the supercritical fluid method: comparison with the modified conventional Bangham methodOptimized formulation of solid self-microemulsifying sirolimus delivery systemsPreparation and evaluation of solid dispersions of a new antitumor compound based on early-stage preparation discovery concept.Preparation, characterization, and in vivo evaluation of tanshinone IIA solid dispersions with silica nanoparticles.The Need for Restructuring the Disordered Science of Amorphous Drug Formulations.Itraconazole solid dispersion prepared by a supercritical fluid technique: preparation, in vitro characterization, and bioavailability in beagle dogsInfluence of hydrophilic additives on the supersaturation and bioavailability of dutasteride-loaded hydroxypropyl-β-cyclodextrin nanostructures.Amorphous Nanoparticulate Formulation of Sirolimus and Its Tablets
P2860
Q33633294-24D2A156-418B-4C25-91CC-5B002F15DA3DQ34502137-23F1EF66-B4C5-4F41-962B-2FE5184E3352Q35087664-48DED966-5C93-431D-8FA3-1C9BDD9D5F63Q35168690-47638B19-3221-42A7-BD51-D83E15E08BFDQ35723500-49CB9612-032A-474C-AA77-C7A0C6096A9DQ35935044-BF372F77-F8ED-4AAE-A0AE-318B6CB3FFCDQ36079945-786559E1-F4CA-42D3-AE3B-E3A166B15426Q36273801-ED43395A-A81A-4FEC-8BB0-906FC158CAACQ36433678-83108786-5EED-4D52-A11E-C15F50FB8257Q36455205-7E24B4BA-99C1-4606-AD3F-DB2813963368Q36567529-949B1F41-797C-4156-BCB1-96193701F092Q36805040-C2911745-D87B-41AB-9E6C-F8B52A4FB914Q36882074-46014F8B-E8A2-485C-B85C-81DA683C2299Q36975416-392C3432-5C81-4C81-A960-85A3216EF734Q39317255-1713D830-D397-4E5F-9826-761C802539F3Q40851361-1C25AD8D-FDFC-47EB-BF17-892B64003E6DQ41310160-0FFF5FF1-2A17-492D-86D6-64CFD9581BF5Q58749798-E6B69500-6900-4C7E-BC5B-9F24123C1174
P2860
Enhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent process.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Enhanced bioavailability of si ...... rcritical antisolvent process.
@ast
Enhanced bioavailability of si ...... rcritical antisolvent process.
@en
type
label
Enhanced bioavailability of si ...... rcritical antisolvent process.
@ast
Enhanced bioavailability of si ...... rcritical antisolvent process.
@en
prefLabel
Enhanced bioavailability of si ...... rcritical antisolvent process.
@ast
Enhanced bioavailability of si ...... rcritical antisolvent process.
@en
P2093
P2860
P356
P1476
Enhanced bioavailability of si ...... ercritical antisolvent process
@en
P2093
Hee Jun Park
Jeong-Soo Kim
Kwang-Ho Cha
Min-Soo Kim
Won Kyung Cho
P2860
P304
P356
10.2147/IJN.S26546
P407
P577
2011-11-24T00:00:00Z